Influence of antecedent of hypertension in patients with acute coronary syndrome without ST elevation;Influencia del antecedente de hipertensión arterial en los pacientes ingresados por síndrome coronario agudo sin elevación del segmento ST

Medicina Clinica

Volumn 126, Issue 4, 2006, Pages 121-124

  Fácila, Lorenzo ^a   Bertomeu, Vicente ^a   Núñez, Julio ^a   Sanchis, Juan ^a   Bodí, Vicent ^a   Consuegra, Luciano ^a   Bosch, M José ^a   Roselló, Araceli ^a   Martínez, Ángel ^a   Blasco, María L ^a   Llàcer, Àngel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Cardiovascular risk; Hypertension; Management; Myocardial ischemia; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; ST SEGMENT ELEVATION;

EID: 33644552783     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13084019     Document Type: Article

References (25)

1. Antman EM, Corbalán R, Kaul P, Jaffe AS. Issues in early risk stratification for UA/NSEMI. Eur Heart J. 2001;3:6-14.
2. Bodí V, Sanchis J, Llàcer A, Fácila L, Núñez J, Pellicer M, et al. Indicadores pronósticos del sindrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2003;56:857-64.
3. Sanchis J, Bodí V, Llàcer A, Fácila L, Núñez J, Rosello A, et al. Predictors of short-term outcome in acute chest pain without ST-segment elevation. Int J Cardiol. 2003;92:193-9.
4. Bassan R, Gibler WB. Unidades de dolor torácico: estado actual del manejo de pacientes con dolor torácico en los servicios de urgencias. Rev Esp Cardiol. 2001;54:1103-9.
5. Sanchis J, Bodí V, Llàcer A, Núñez J, Ferrero JA, Chorro FJ. Valor de la prueba de esfuerzo precoz en un protocolo de unidad de dolor torácico. Rev Esp Cardiol. 2002;55:1089-92.
6. Kaul P, Fu Y, Chang WC, Harrington RA, Wagner GS, Goodman SG, et al. Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol. 2001;38:64-71.
7. Hamm CW. Cardiac biomarkers for rapid evaluation of chest pain. Circulation. 2001;104:1454-6.
8. Sabatine MS, Morrow DA, De Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105:1760-3.
9. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343:1139-47.
10. Sonel A, Sasseen BM, Fineberg N, Bang N, Wilensky RL. Prospective study correlating fibrino-peptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation. 2000;102:1107-13.
11. Bodí V, Fácila L, Sanchis J, Llàcer A, Núñez J, Mainar L, et al. Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmenta ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda. Rev Esp Cardiol. 2002;55:823-30.
12. Willich SN, Muller-Nordhorn J, Kulig M, Binting S, Gohlke H, Hahmann H, et al. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study. Eur Heart J. 2001;22:307-13.
13. Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358-63.
14. Majahalme SK, Smith DE, Cooper JV, Kline-Rogers E, Mehta RH, Eagle KA, et al. Comparison of patients with acute coronary syndrome with and without systemic hypertension. Am J Cardiol. 2003;92:258-63.
15. Haider AW, Chen L, Larson MG, Evans JC, Chen MH, Levy D. Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction. Hypertension. 1997;30:1020-4.
16. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol. 2003;42:1446-53.
17. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: the Framingham study. Am J Cardiol. 1980;45:326-30.
18. Rabkin SW, Mathewson FA, Tate RB. Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol. 1977;40:604-10.
19. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-69.
20. Herlitz J, Karlson BW, Lindqvist J, Sjolin M. Prognosis during five years of follow-up among patients admitted to the emergency department with acute chest pain in relation to a history of hypertension. Blood Press. 1998;7:81-8.
21. Herlitz J, Karlson BW, Lindqvist J, Sjolin M. Important factors for the 10-year mortality rate in patients with acute chest pain or other symptoms consistent with acute myocardial infarction with particular emphasis on the influence of age. Am Heart J. 2001;142:624-32.
22. Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2004;93:288-93.
23. López-Minguez JR, Fuentes ME, Doblado M, Merchán A, Martínez A, González R, et al. Papel pronóstico de la hipertension arterial y de la diabetes mellitus en los pacientes con angina inestable tratados con stents coronarios. Rev Esp Cardiol. 2003;56:987-94.
24. Fadl YY, Zareba W, Moss AJ, Marder VJ, Sparks CS, Miller Watelet LF, et al. History of hypertension and enhanced thrombogenic activity in postinfarction patients. Hypertension. 2003;41:943-9.
25. Juanatey JR, Ezquerra EA, Vidal JV, Caro JL, Acuna JG, Maqueda IG. Impacto de la hipertensión en las cardiopatías en España. Estudio Cardiotens 1999. Rev Esp Cardiol. 2001;54:139-49.